Trans-sialidase from Trypanosoma brucei as a potential target for DNA vaccine development against African trypanosomiasis

Parasitology Research

Volumn 105, Issue 5, 2009, Pages 1223-1229

  Silva, Marcelo Sousa ^a,b   Prazeres, Duarte Miguel F ^b   Lança, Andreia ^a   Atouguia, Jorge ^a   Monteiro, Gabriel Amaro ^b  

^a INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^b INSTITUTO SUPERIOR TÉCNICO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; IMMUNOGLOBULIN G; PLASMID DNA; PROTOZOAL PROTEIN; SIALIDASE; TRANS SIALIDASE; TRYPANOSOMA VACCINE; UNCLASSIFIED DRUG;

AFRICAN TRYPANOSOMIASIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; DNA IMMUNIZATION; ESCHERICHIA COLI; HUMORAL IMMUNITY; INFECTION PREVENTION; MOUSE; NONHUMAN; PARASITE IMMUNITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTOZOAL GENETICS; PROVOCATION TEST; SINGLE DRUG DOSE; TRYPANOSOMA BRUCEI;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ESCHERICHIA COLI; GLYCOPROTEINS; IMMUNOGLOBULIN G; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED BALB C; NEURAMINIDASE; PROTEIN BINDING; PROTOZOAN VACCINES; RECOMBINANT PROTEINS; SURVIVAL ANALYSIS; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN; VACCINES, DNA;

ANIMALIA; BOS; ESCHERICHIA COLI; MUS; PROTOZOA; TRYPANOSOMA BRUCEI;

EID: 70349593708     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-009-1542-6     Document Type: Article

References (39)

1. RJ Anderson J Schneider 2007 Plasmid DNA and viral vector-based vaccines for the treatment of cancer Vaccine 25S B24 B34 10.1016/j.vaccine.2007.05.030 (Pubitemid 47489798)
2. +-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2 Infec Immun 73 6017 6025 10.1128/IAI.73.9.6017- 6025.2005 (Pubitemid 41193040)
3. JM Atouguia FW Jennings M Murray 1995 Successful treatment of experimental murine Trypanosoma brucei infection with topical melarsoprol gel Trans Royal Soc Trop Med Hyg 89 531 533 10.1016/0035-9203(95)90098-5 1:STN:280:DyaK287kt1yjsg%3D%3D
4. F Costa G Franchin VL Pereira-Chiocola M Ribeirão S Schenkman MM Rodrigues 1998 Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice Vaccine 16 768 774 9627933 10.1016/S0264-410X(97)00277-6 1:CAS:528:DyaK1cXjslOlsLo%3D (Pubitemid 28236645)
5. F Costa VL Pereira-Chioccola M Ribeirão S Schenkman MM Rodrigues 1999 Trans-sialidase delivered as a naked DNA vaccine elicits na immunological response similar to a Trypanosoma cruzi infection Braz J Med Biol Res 32 235 239 10347760 1:CAS:528:DyaK1MXhslOlsL8%3D
6. MM Diogo JA Queiroz GA Monteiro SAM Martins GNM Ferreira DMF Prazeres 2000 Purification of a cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography Biotechnol Bioeng 68 576 583 10797245 10.1002/(SICI)1097-0290(20000605)68:5<576::AID-BIT13>3.0.CO;2-5 1:CAS:528:DC%2BD3cXjt1GrtbY%3D (Pubitemid 30307729)
7. JJ Donnelly A Friedman JB Ulmer MA Liu 1997 Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination Vaccine 15 865 868 9234535 10.1016/S0264-410X(96)00268-X 1:CAS:528:DyaK2sXkslert7s%3D (Pubitemid 27287977)
8. JJ Donnelly B Wahren MA Liu 2005 DNA vaccines: progress and challenges J Immunol 175 633 639 16002657 1:CAS:528:DC%2BD2MXlvFSjs7w%3D
9. DL Doolan M Sedegah RC Hedstrom P Hobart Y Charoenvit SL Hoffman 1996 Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ T cell-, interferon gamma, and nitric oxide-dependent immunity J Exp Med 83 1739 1746 10.1084/jem.183.4.1739 (Pubitemid 26134315)
10. MB Drennan B Stijlemans JVD Abbeele VJ Quesniaux M Barkhuizen F Brombacher P De Baetselier B Ryffel S Magez 2005 The induction of a type 1 immune response following a Trypanosoma brucei infection is MyD88 dependent J Immunol 175 2501 2509 16081822 1:CAS:528:DC%2BD2MXntVSqsrY%3D
11. PD Eckersall JW Gow C McComb B Bradley J Rodgers M Murray PGE Kennedy 2001 Cytokines and the acute phase response in post-treatment reactive encephalopathy of Trypanosoma brucei brucei infected mice Parasit Intern 50 15 26 10.1016/S1383-5769(00)00065-9 1:CAS:528:DC%2BD3MXitVOlt7s%3D (Pubitemid 32215488)
12. JH Fernandes JM Atouguia MC Peleteiro FW Jenning VE Rosário 1997 Post-treatment hind-leg paralysis in mice infected with Trypanosoma brucei brucei: a light microscopic study Acta Trop 63 179 184 9088431 10.1016/S0001-706X(96)00614-6 1:STN:280:DyaK2s3ktlGrsA%3D%3D (Pubitemid 27148047)
13. W Gao MA Pereira 2001 Trypanosoma cruzi trans-sialidase potentiates T cell activation through antigen-presenting cells: role of IL-6 and Bruton's tyrosine kinase Eur J Immunol 31 1503 1512 11465107 10.1002/1521-4141(200105)31: 5<1503::AID-IMMU1503>3.0.CO;2-W 1:CAS:528:DC%2BD3MXktVWju7k%3D (Pubitemid 32454698)
14. N Garg RL Tarleton 2002 Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection Infect Immun 70 5547 5555 12228281 10.1128/IAI.70.10.5547-5555.2002 1:CAS:528:DC%2BD38XnsV2lsL8%3D (Pubitemid 35050989)
15. D Golgher RT Gazzinelli 2004 Innate and adquired immunity in the pathogenesis of Chagas disease Autoimmunity 37 399 409 15621564 10.1080/08916930410001713115 1:CAS:528:DC%2BD2cXhtVOmsrjK (Pubitemid 40100698)
16. MD Halpern RJ Kurlander DS Pisetsky 1996 Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha Cell Immunol 167 72 78 8548847 10.1006/cimm.1996.0009 1:CAS:528:DyaK28XmtVCqsQ%3D%3D (Pubitemid 26048848)
17. CJ Hertz H Filutowicz JM Manstield 1998 Resistance to the African trypanosomes is IFN-gamma dependent J Immunol 161 6775 6783 9862708 1:CAS:528:DyaK1cXotFWqt7k%3D
18. + CTL and B cell-mediated cross-priming J Immunol 179 6889 6900 17982080 1:CAS:528:DC%2BD2sXht1Crs7%2FK
19. FW Jennings 1993 Combination chemotherapy of CNS trypanosomiasis Acta Trop 54 205 213 7902658 10.1016/0001-706X(93)90093-Q 1:STN:280: DyaK2c%2FntVGjtQ%3D%3D
20. PGE Kennedy 2000 The pathogenesis and modulation of post-treatment reactive encephalopathy in a mouse model of human African trypanosomiasis J Neuroimmunol 100 36 41 10.1016/S0165-5728(99)00196-4
21. AM Krieg YI Ak S Matison TJ Waldschmidt GA Bishop R Teasdale GA Koretzky DM Klinman 1995 CpG motifs in bacterial DNA trigger direct B-cell actvation Nature (Lond) 374 546 549 10.1038/374546a0 1:CAS:528:DyaK2MXkvVKqtr8%3D
22. SM Lanham DG Godfrey 1970 Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose Exp Parasitol 28 521 534 4993889 10.1016/0014-4894(70)90120-7 1:STN:280:DyaE3M7jt12ktA%3D%3D
23. C Leclerc E Dériaud M Rojas RG Whalen 1997 The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA Cel Immunol 179 97 106 10.1006/cimm.1997.1161 1:CAS:528:DyaK2sXmtlOhsrg%3D (Pubitemid 27400500)
24. Y Liu E Ragaa Z Li L Nuortio A Mustafa M Bakhiet 1999 Interferon-gamma and interleukin-12 genes are preferentially expressed during early experimental African trypanosomiasis and suppressed by denervation of the spleen Scand J Immunol 50 485 491 10564551 10.1046/j.1365-3083.1999.00639.x 1:CAS:528:DyaK1MXnsVWjsrw%3D (Pubitemid 29503454)
25. G Montagna ML Cremona G Paris MF Amaya A Buschuazzi PM Alzari AC Frasch 2002 The trans-sialidase from the African trypanosome Trypanosoma brucei Eur J Biochem 269 2941 2950 12071958 10.1046/j.1432-1033.2002.02968.x 1:CAS:528:DC%2BD38XltF2gsL0%3D (Pubitemid 34754023)
26. GN Montagna JE Donelson ACC Frasch 2006 Procyclic Trypanosoma brucei expresses separate sialidase and trans-sialidase enzymes on its surface membrane J Biol Chem 281 33949 33958 16956887 10.1074/jbc.M604951200 1:CAS:528:DC%2BD28XhtFKgtbjI (Pubitemid 46036607)
27. B Namangala W Noel P De Baetselier L Brys A Beschin 2001 Relative contribution of interferon-gamma and interleukin-10 to resistance to murine African trypanosomosis J Infect Dis 183 1794 1800 11372033 10.1086/320731 1:CAS:528:DC%2BD3MXkvFenurk%3D (Pubitemid 32523243)
28. J Neres RA Bryce KT Douglas 2008 Rational drug design in parasitology: trans-sialidase as a case study for Chagas disease Drug Disc Today 13 110 117 10.1016/j.drudis.2007.12.004 1:CAS:528:DC%2BD1cXitVemsro%3D
29. G Otten M Schaefer B Doe H Liu I Srivastava JZ Megede D O'Hagan J Donnelly G Widera D Rabussay MG Lewis S Barnett JB Ulmer 2004 Enhancement of DNA vaccine potency in rhesus macaques by electroporation Vaccine 22 2489 2493 15193413 10.1016/j.vaccine.2003.11.073 1:CAS:528:DC%2BD2cXkvVemtb0%3D (Pubitemid 38757348)
30. VL Pereira-Chioccola F Costa M Ribeirão IS Soares F Arena S Schenkman MM Rodrigues 1999 Comparison of antibody and protective immune responses against Trypanosoma cruzi infection elicited by immunization with a parasite antigen delivered as naked DNA or recombinant protein Parasitol Immunol 21 103 110 10.1046/j.1365-3024.1999.00201.x 1:CAS:528:DyaK1MXltFOrsb8%3D (Pubitemid 29086310)
31. VL Pereira-Chiocola AA Fragata-Filho AM Levy MM Rodrigues S Schenkman 2003 Enzyme-linked immunoassay using recombinant trans-sialidase of Trypanosoma cruzi can be employed for monitoring of patients with Chagas' disease after drug treatment Clin Diagn Lab Immunol 10 826 830
32. E Raz H Tighe Y Sato M Corr JA Dudler M Roman SL Swain HL Spiegelberg DA Carson 1996 Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization Proc Natl Acad Sci USA 93 5141 5145 8643542 10.1073/pnas.93.10.5141 1:CAS:528:DyaK28XjtVKlu78%3D (Pubitemid 26162885)
33. S Schenkman M Jiang GW Hart V Nussenzweig 1991 A novel cell surface trans-sialidase of Trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells Cell 65 1117 1125 1712251 10.1016/0092-8674(91) 90008-M 1:CAS:528:DyaK3MXmt1Oru7k%3D
34. LR Schopf H Filutowicz X Bi JM Mansfield 1998 Interleukin-4 dependent immunoglobulin G1 isotypes switch in the presence of a polarized antigen-specific Th1-cell response to the trypanosome variant surface glycoprotein Infect Immun 66 451 461 9453595 1:CAS:528:DyaK1cXmslOmsw%3D%3D
35. PP Simarro J Jannin P Cattand 2008 Eliminating human African trypanosomiasis: where do we stand and what comes next? PLoS Medicine 5 174 180 10.1371/journal.pmed.0050055 (Pubitemid 351317643)
36. + T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909 J Clin Invest 115 739 746 15696196 1:CAS:528:DC%2BD2MXit1emt7o%3D
37. FK Stenvenson CH Ottensmeier P Johnson D Zhu SL Buchan KJ McCann JS Roddick AT King F McNicholl N Savelyeva J Rice 2004 DNA vaccines to attack cancer Proc Natl Acad Sci USA 101 14646 14652 10.1073/pnas.0404896101 (Pubitemid 39346737)
38. MV Tribulatti J Mucci NV Rooijen MS Leguizámon O Campetella 2005 The trans-sialidase from Trypanossoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents Infect Immun 73 201 207 15618155 10.1128/IAI.73.1.201-207.2005 1:CAS:528: DC%2BD2MXisFyjsQ%3D%3D (Pubitemid 40041110)
39. JE Uzonna RS Kaushik JR Gordon H Tabel 1998 Experimental murine Trypanosoma congolense infections. I. Administration of anti-IFN-gamma antibodies alters trypanosome-susceptible mice to a resistance-like phenotype J Immunol 161 5507 5515 9820527 1:CAS:528:DyaK1cXnsVOqsL0%3D